Main > A1. CORP. INDEX. Pn-Pz > Point Biopharma Inc./P C2

2020

Point Biopharma Inc./P C2's subsections
2020. 03.10. Licensor
2020. 11.10. Pan-Cancer Targeting
2021. 01.07. Licensor
2021. 11.24. Licensor
2023. 10.03. Acq. By Eli Lilly
2023. 12.27. Acq. By Eli Lilly
web-site

Point Biopharma Inc./P C2's products
This section has no products